FDA Action Alert: Urovant, Athenex, scPharmaceuticals and Vertex
The Pharma Data
DECEMBER 20, 2020
Athenex and Almirall have a license deal with Almirall having the license to research, develop and commercialize the drug in the U.S. The FDA approval of Klisyri is a significant milestone for Athenex,” said Johnson Lau, chairman and chief executive officer of Athenex. and Europe, including Russia. Most Read Today.
Let's personalize your content